Business Small Business

Saturday 24 March 2018

Irish medtech company starts working with the NHS

Pictured at NovaUCD are William Cirillo and John Hughes, co-founders, Innovation Zed
Pictured at NovaUCD are William Cirillo and John Hughes, co-founders, Innovation Zed
Ellie Donnelly

Ellie Donnelly

Innovation Zed, an Irish medtech company, has commenced working with the NHS in South Yorkshire and Bassetlaw, England.

The work will see the company’s insulin pen accessory used with diabetes patients as part of a national NHS Test Bed programme exploring new models of care.

InsulCheck Connect, a snap-on accessory for disposable insulin pen users, automatically collects and records pen usage and behaviour data 'on the go'.

The InsulCheck Connect device is being offered to diabetic patients at the Northern General Hospital, Sheffield as part of a programme designed to better support them to manage their condition.

It is hoped the programme will involve up to 300 diabetes patients in total.

Read more: Mainstay back pain treatment clinical trial passes mid-way point

The data collected by the device, when merged with other data such as sugar level readings, will then enable diabetic patients and their medical professionals to improve the management of the condition and generate better health outcomes.

Innovation Zed, which is headquartered at NovaUCD, was founded in 2009 by John Hughes and William Cirillo.

Commenting on the announcement, Mr Hughes said that he was "delighted" to have the device incorporated into the test bed programme in England.

"Our research with insulin pen users highlights that, as with other conditions, injection compliance is significantly below what is prescribed. We firmly believe that this work will demonstrate that our insulin pen accessory can greatly improve injection compliance and generate better health outcomes for people with diabetes," Mr Hughes said.

While Liz Howarth, South Yorkshire and Bassetlaw Perfect Patient Pathway Test Bed programme director said that they were looking forward to working with "our partners, patients and the evaluation team to assess the impact of this particular project."

Online Editors

Business Newsletter

Read the leading stories from the world of Business.

Also in Business